23/01/2025  21:16:34 Chg. +0.900 Volume Bid21:16:34 Demandez à21:16:34 Capitalisation boursière Dividende Y. Rapport P/E
144.950EUR +0.62% 7,776
Chiffrre d'affaires: 1.13 Mio.
144.050Bid taille: 100 144.950Ask la taille: 100 18.66 Mrd.EUR 1.52% 22.25

Description de l'entreprise

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 52,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
 

Conseil d'administration & Conseil de surveillance

PDG
Belén Garijo
Conseil d'administration
Helene von Roeder, Dr. Kai Beckmann, Matthias Heinzel, Peter Guenter
Conseil de surveillance
Michael Kleinemeier, Sascha Held, Anne Lange, Dietmar Oeter, Simon Thelen, Birgit Biermann, Katja Garcia Vila, Carla Kriwet, Barbara Lambert, Stefan Palzer, Alexander Putz, Christian Raabe, Michael Reinhart, Susanne Schaffert, Sandra Schwebke, Daniel Thelen
 

Données de l'entreprise

Nom: Merck KGaA
Adresse: Frankfurter Str. 250,D-64293 Darmstadt
Téléphone: +49-6151-72-0
Fax: +49-6151-72-2000
Courriel: service@merckgroup.com
Internet: www.merck.de
Industrie: Healthcare
Secteur: Pharmaceutical Industry
Sous-secteur: Pharmaceuticals
Fin de l'exercice financier: 31/12
Flotte libre: 66.28%
IPO date: 20/10/1995

Relations avec les investisseurs

Nom: Constantin Fest
Téléphone IR: +49-6151-72-3321
IR-Fax: +49-6151-72-91-3321
E-mail IR: investor.relations@m...oup.com investor.relations@merckgroup.com

Calendrier de l'entreprise

CW 10 | 06/03/2025 Annual Report
CW 17 | 25/04/2025 General Shareholder Meeting
CW 20 | 15/05/2025 Interim Report 1st Quarter/3 Months
CW 32 | 07/08/2025 Interim Report 2nd Quarter/6 Months
CW 46 | 13/11/2025 Interim Report 3rd Quarter/9 Months
 

Principaux actionnaires

Autres
 
73.64%
BlackRock, Inc.
 
7.43%
Massachusetts Financial Services Company
 
5.06%
Sun Life Financial Inc.
 
4.91%
FMR LLC
 
3.02%
Amundi S.A.
 
2.99%
DWS Investment GmbH
 
2.95%